219 related articles for article (PubMed ID: 10679091)
1. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 2000 Mar; 164(5):2533-41. PubMed ID: 10679091
[TBL] [Abstract][Full Text] [Related]
2. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 1998 Nov; 161(9):4627-33. PubMed ID: 9794391
[TBL] [Abstract][Full Text] [Related]
3. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
4. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2.
Martino A; Holmes JH; Lord JD; Moon JJ; Nelson BH
J Immunol; 2001 Feb; 166(3):1723-9. PubMed ID: 11160217
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
Moon JJ; Nelson BH
J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
[TBL] [Abstract][Full Text] [Related]
7. Bcr/Abl activates transcription of the Bcl-X gene through STAT5.
Gesbert F; Griffin JD
Blood; 2000 Sep; 96(6):2269-76. PubMed ID: 10979976
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling.
Nelson BH; Martyak TP; Thompson LJ; Moon JJ; Wang T
J Immunol; 2003 Jun; 170(11):5563-70. PubMed ID: 12759434
[TBL] [Abstract][Full Text] [Related]
9. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
[TBL] [Abstract][Full Text] [Related]
10. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
Delespine-Carmagnat M; Bouvier G; Bertoglio J
Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
[TBL] [Abstract][Full Text] [Related]
11. An IL-2 receptor beta subdomain that controls Bcl-X(L) expression and cell survival.
Ciprés A; Gala S; Martinez-A C; Mérida I; Williamson P
Eur J Immunol; 1999 Apr; 29(4):1158-67. PubMed ID: 10229082
[TBL] [Abstract][Full Text] [Related]
12. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
[TBL] [Abstract][Full Text] [Related]
13. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
[TBL] [Abstract][Full Text] [Related]
14. Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase.
Morcinek JC; Weisser C; Geissinger E; Schartl M; Wellbrock C
Oncogene; 2002 Mar; 21(11):1668-78. PubMed ID: 11896598
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL
J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780
[TBL] [Abstract][Full Text] [Related]
16. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation.
Ascherman DP; Migone TS; Friedmann MC; Leonard WJ
J Biol Chem; 1997 Mar; 272(13):8704-9. PubMed ID: 9079703
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
Chida D; Wakao H; Yoshimura A; Miyajima A
Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
[TBL] [Abstract][Full Text] [Related]
19. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
Antov A; Yang L; Vig M; Baltimore D; Van Parijs L
J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638
[TBL] [Abstract][Full Text] [Related]
20. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction.
Nakajima H; Liu XW; Wynshaw-Boris A; Rosenthal LA; Imada K; Finbloom DS; Hennighausen L; Leonard WJ
Immunity; 1997 Nov; 7(5):691-701. PubMed ID: 9390692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
